Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

EBioMedicine- Netherlands

doi 10.1016/j.ebiom.2016.04.010

Related search

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

English

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Molecular Therapy - Methods and Clinical Development

English

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet

Medicine

2017

English

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

American Journal of Tropical Medicine and Hygiene

English

Development of a Novel Recombinant BCG for Tuberculosis Vaccine

Japanese Journal of Leprosy

English

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

English

Identification of DNA Methylation Patterns Predisposing for an Efficient Response to BCG Vaccination in Healthy BCG-naïve Subjects

English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases

English

A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly

Human Vaccines and Immunotherapeutics

English

Amanote Research

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

EBioMedicine- Netherlands

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

Development of a Novel Recombinant BCG for Tuberculosis Vaccine

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Identification of DNA Methylation Patterns Predisposing for an Efficient Response to BCG Vaccination in Healthy BCG-naïve Subjects

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly